A. M. Molesworth, M. C. Thomson, S. J. Connor, M. P. Cresswell, and A. P. Morse, Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa, Trans R Soc Trop Med Hyg, vol.96, pp.242-249, 2002.

B. D. Gessner, J. E. Mueller, and S. Yaro, African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults, BMC Infect Dis, vol.10, p.22, 2010.

Y. Traore, T. A. Tameklo, B. M. Njanpop-lafourcade, M. Lourd, and S. Yaro, Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo, Clin Infect Dis, vol.48, pp.181-189, 2009.

E. Tikhomirov, M. Santamaria, and K. Esteves, Meningococcal disease: public health burden and control, World Health Stat Q, vol.50, pp.170-177, 1997.

R. T. Novak, J. L. Kambou, F. Diomande, T. F. Tarbangda, and R. Ouedraogo-traore, Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data, Lancet Infect Dis, vol.12, pp.757-764, 2012.

P. A. Kristiansen, F. Diomande, A. K. Ba, I. Sanou, and A. S. Ouedraogo, Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity, Clin Infect Dis. Epub, 2012.

F. T. Cutts, S. M. Zaman, G. Enwere, S. Jaffar, and O. S. Levine, Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebocontrolled trial, Lancet, vol.365, pp.1139-1146, 2005.

I. Delrieu, S. Yaro, T. A. Tamelkoe, B. M. Njanpop-lafourcade, and H. Tall, Emergence of epidemic Neisseria meningtidis serogroup X meningitis in Togo and Burkina Faso, PLoS One, vol.6, p.19513, 2011.

J. E. Mueller, R. Borrow, and B. D. Gessner, Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity, and vaccines, Expert Rev Vaccines, vol.5, pp.319-355, 2006.

Y. H. Choi, M. Jit, N. Gay, N. Andrews, and P. A. Waight, 7-valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?, PLoS One, vol.6, p.26190, 2011.

J. B. Ndihokubwayo, F. Kasolo, A. A. Yahay, and J. Mwenda, Strengthening public health laboratories in the WHO African Region: a critical need for disease control, The African Health Monitor, vol.12, pp.47-52, 2010.

R. T. Ouedraogo, B. M. Njanpop-lafourcade, P. Jaillard, Y. Traore, and J. E. Mueller, Mobile laboratory to improve response to meningitis epidemics, Burkina Faso epidemic season, FACTS Rep, vol.1, 2004.

, Distinguising public health research and public health nonresearch. Science administration document CDC-SA-2010-02. Date of issue, 2010.

G. W. Ajello, J. C. Feeley, P. S. Hayes, A. L. Reingold, and G. Bolan, Transisolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, J Clin Microbiol, vol.20, pp.55-58, 1984.

M. K. Taha, Simultaneous Approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis, J Clin Microbiol, vol.38, pp.855-857, 2000.

I. Parent-du-châtelet, Y. Traore, B. D. Gessner, A. Antignac, and B. Naccro, Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing, Clin Infect Dis, vol.40, pp.17-25, 2005.

P. Boisier, P. Nicolas, S. Djibo, M. Taha, and J. I. , Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger, Clin Infect Dis, vol.44, pp.657-63, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00561840

M. K. Taha, D. Giorgini, M. Ducos-galand, and J. M. Alonso, Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000, J Clin Microbiol, vol.42, pp.4158-4163, 2004.

A. J. Fox, M. K. Taha, and U. Vogel, Standardized nonculture techniques recommended for European reference laboratories, FEMS Microbiol Rev, vol.31, pp.84-88, 2007.

J. E. Mueller, L. Sangare, B. M. Njanpop-lafourcade, Z. Tarnagda, and Y. Traore, Molecular characteristics and epidemiology of meningococcal carriage, Emerg Infect Dis, vol.13, pp.847-854, 2003.

Y. Traore, B. M. Njanpop-lafourcade, K. L. Adjogble, M. Lourd, and S. Yaro, The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, Clin Infect Dis, vol.43, pp.817-822, 2002.

S. Djibo, P. Nicolas, J. M. Alonso, A. Djibo, and D. Couret, Outbreaks of serogroup X meningococcal meningitis in Niger, Trop Med Int Health, vol.8, pp.1118-1123, 1995.

S. P. Gagneux, A. Hodgson, T. A. Smith, T. Wirth, and I. Ehrhard, Prospective study of a serogroup X Neisseria meningtidis outbreak in northern Ghana, J Infect Dis, vol.185, pp.618-626, 2002.

J. Leimkugel, A. Forgor, A. Gagneux, S. Pfluger, V. Flierl et al., An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics, J Infect Dis, vol.192, pp.192-199, 2005.

S. Yaro, M. Lourd, Y. Traore, B. M. Njanpop-lafourcade, and A. Sawadogo, Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso, Clin Infect Dis, vol.43, pp.693-700, 2006.